[
    [
        {
            "time": "",
            "original_text": "控股股东上实集团增持上海医药(02607) 865.79万股，每股作价14.66港元",
            "features": {
                "keywords": [
                    "控股股东",
                    "上实集团",
                    "增持",
                    "上海医药",
                    "865.79万股",
                    "14.66港元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "控股股东上实集团增持上海医药(02607) 865.79万股，每股作价14.66港元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【权益变动】上海医药(02607-HK)获控股股东上实集团增持865.79万股",
            "features": {
                "keywords": [
                    "权益变动",
                    "上海医药",
                    "控股股东",
                    "上实集团",
                    "增持",
                    "865.79万股"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【权益变动】上海医药(02607-HK)获控股股东上实集团增持865.79万股",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "90后成线上购买主力: 医药保健品前三季进口增35.5%",
            "features": {
                "keywords": [
                    "90后",
                    "线上购买",
                    "医药保健品",
                    "进口增长",
                    "35.5%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "保健品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "90后成线上购买主力: 医药保健品前三季进口增35.5%",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]